在乳腺癌中,SNORA5A通过TRAF3IP3调节与瘤相关的巨细胞M1/M2表型
Yiqi Zhang1, Ang Zheng2, Yue Shi1
1Department of Surgery, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.
概括
小核核RNA SNORA5A在乳腺癌中下调,影响瘤相关的巨细胞表型和患者预后. 它通过TRAF3IP3调节巨细胞,这表明它有可能成为治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 小核RNAs (snoRNAs) 在乳腺癌治疗方面表现有前途.
- 在乳腺癌中SNORA5A的特定作用仍然在很大程度上未被探索.
研究的目的:
- 研究SNORA5A在乳腺癌中的功能和预后价值.
- 阐明SNORA5A,瘤相关的巨细胞和潜在的下游标之间的关系.
主要方法:
- 癌症基因组图谱 (TCGA) 转录矩阵和使用R软件的临床数据的分析.
- 在临床乳腺癌组织样本中验证发现.
- 生物信息分析以确定下游分子和相关功能.
主要成果:
- 在乳腺癌组织中,SNORA5A的下调显著.
- 高SNORA5A表达与良好的预后和调节的M1/M2巨细胞平衡相关.
- TRAF3IP3被确定为由SNORA5A调节的下游分子,影响巨细胞两极分化.
结论:
- 在乳腺癌中,SNORA5A在调节巨细胞表型方面发挥着至关重要的作用,可能是通过TRAF3IP3.
- SNORA5A是一种有前途的预后生物标志物和乳腺癌的治疗点.
更多相关视频
06:38Macrophage Differentiation and Polarization into an M2-Like Phenotype using a Human Monocyte-Like THP-1 Leukemia Cell Line
Published on: August 2, 2021
27.4K
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
2.6K
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
